Showing 521-530 of 1560 results for "".
Weekly Check-up | April 4th 2016
https://reachmd.com/programs/the-weekly-check-up/weekly-check-april-4th-2016/8037/Welcome to the Weekly Check-up on ReachMD for the week of April 4th, 2016.From Pathway to Patient: Clinical Advances in PI3K-Directed Therapy for HR+/HER2- mBC
https://reachmd.com/programs/cme/From-Pathway-to-Patient-Clinical-Advances-in-PI3K-Directed-Therapy-for-HR-HER2-mBC/35975/Join Drs. Jhaveri and Kalinsky and get up to speed on the latest data on PI3K-directed therapies and their role in the treatment paradigm for HR+, HER2- mBC.Silent Threats in a Pandemic: The Emotional Tolls of Self-Isolation
https://reachmd.com/programs/covid-19-frontlines/silent-threats-pandemic-emotional-tolls-self-isolation/11344/Clinicians at high risk of exposure from COVID-19 are facing difficult choices about how to keep their loved ones safe.CDH6 in Focus: Advancing Biomarker-Driven Strategies for Platinum-Resistant Ovarian Cancer
https://reachmd.com/programs/cme/cdh6-in-focus-advancing-biomarker-driven-strategies-for-platinum-resistant-ovarian-cancer/36229/CDH6 in Focus: Advancing Biomarker-Driven Strategies for Platinum-Resistant Ovarian CancerOptimizing the Screening of Precursor Diseases in Multiple Myeloma
https://reachmd.com/programs/project-oncology/optimizing-the-screening-of-precursor-diseases-in-multiple-myeloma/27008/Learn about our current approach to screening patients for precursor diseases in multiple myeloma and how we may be able to optimize it.The Necessity of a Multidisciplinary Approach Through the mCRPC Treatment Journey
https://reachmd.com/programs/project-oncology/the-necessity-of-a-multidisciplinary-approach-through-the-mcrpc-treatment-journey/17802/A multidisciplinary care approach is pivotal in the disease continuum of mCRPC. Here’s why.The Gene Messenger: Advancing Neurological Gene Therapy
https://reachmd.com/programs/medical-industry-feature/the-gene-messenger-advancing-neurological-gene-therapy/18094/Hear about groundbreaking advances in neurological gene therapy for patients with Parkinson’s disease.Key Considerations for G-CSF Administration in Patients with FN Risk
https://reachmd.com/programs/medical-industry-feature/key-considerations-for-g-csf-administration-in-patients-with-fn-risk/13123/Here’s what you need to keep in mind when administering granulocyte colony stimulating factors for primary prophylaxis of febrile neutropenia.New Successes with Gene Therapy
https://reachmd.com/programs/focus-on-future-medicine-and-genetics/new-successes-with-gene-therapy/4444/Although gene therapy has encountered a few significant setbacks in its two-decade history, it has recently demonstrated several notable successes. What conditions have been successfully treated with gene therapy, and might gene therapy some day be used to treat cancer? What are some of the obstacleNavigating the Therapeutic Landscape of Platinum-Resistant Ovarian Cancer
https://reachmd.com/programs/cme/navigating-the-therapeutic-landscape-of-platinum-resistant-ovarian-cancer/37667/CDH6 in Focus: Advancing Biomarker-Driven Strategies for Platinum-Resistant Ovarian Cancer